What is ColoWrap?
ColoWrap, Inc. specializes in a unique compression device for colonoscopies, engineered to eliminate the need for manual abdominal pressure and patient repositioning. This innovation aims to bolster safety and operational efficiency during endoscopic procedures. The companys flagship product, ColoWrap, is designed to elevate colonoscopy quality by reducing cecal intubation times and fostering a more secure environment for both patients and healthcare practitioners. By concentrating on gastrointestinal (GI) professionals, ColoWrap is dedicated to delivering solutions that not only improve patient outcomes but also mitigate the risk of clinical staff injuries commonly associated with traditional endoscopy methods. The company is committed to advancing safer and more effective colonoscopy practices through comprehensive training and robust safety programs.
How much funding has ColoWrap raised?
ColoWrap has raised a total of $149K across 1 funding round:
Debt
$149K
Debt (2021): $149K with participation from PPP
What's next for ColoWrap?
With its recent strategic investment, ColoWrap is poised to accelerate its market expansion and further refine its innovative colonoscopy compression device. The large-scale, late-stage funding context suggests the company is moving towards broader commercialization and potentially scaling its operations to meet increasing demand. Future developments will likely focus on enhancing product adoption among gastrointestinal specialists, expanding its training initiatives, and solidifying its position as a leader in endoscopic safety technology. This capital infusion is expected to fuel research and development for next-generation devices and strengthen its competitive edge in the MedTech landscape.
See full ColoWrap company page
